PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Acquired Cystic Disease-Associated Renal Cell Carcinoma: Review of Pathogenesis, Morphology, Ancillary Tests, and Clinical Features.

Abstract Acquired cystic disease-associated renal cell carcinoma (ACD-RCC) is a recently described subtype of RCC found in individuals with ACD of the kidney. Because of underrecognition, information regarding this lesion is sparse but continues to accumulate with each new report. Herein, a thorough literature review amassing the current understanding of this unique neoplasm is presented. Discussion focuses on clinical features, pathogenesis, disease outcome, and relation to the duration of dialysis. The macroscopic and characteristic microscopic features are described with illustrations. Compared with previous opinion, compiled immunohistochemical data may now allow for recognition of a unique immunophenotypic pattern of ACD-RCC. Distinction of ACD-RCC from clear cell and papillary RCCs based on molecular genetic information is deliberated, including a summary of the most frequently detected cytogenetic abnormalities. The key morphologic and immunophenotypic patterns used to distinguish this entity from a comprehensive differential diagnosis are provided.
PMID
Related Publications

Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y.

Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.

PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.

Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.

Clear cell papillary renal cell carcinoma and clear cell renal cell carcinoma arising in acquired cystic disease of the kidney: an immunohistochemical and genetic study.

Authors

Mayor MeshTerms
Keywords
Journal Title archives of pathology & laboratory medicine
Publication Year Start




PMID- 28353376
OWN - NLM
STAT- MEDLINE
DA  - 20170329
DCOM- 20170418
LR  - 20170418
IS  - 1543-2165 (Electronic)
IS  - 0003-9985 (Linking)
VI  - 141
IP  - 4
DP  - 2017 Apr
TI  - Acquired Cystic Disease-Associated Renal Cell Carcinoma: Review of Pathogenesis, 
      Morphology, Ancillary Tests, and Clinical Features.
PG  - 600-606
LID - 10.5858/arpa.2016-0123-RS [doi]
AB  - Acquired cystic disease-associated renal cell carcinoma (ACD-RCC) is a recently
      described subtype of RCC found in individuals with ACD of the kidney. Because of 
      underrecognition, information regarding this lesion is sparse but continues to
      accumulate with each new report. Herein, a thorough literature review amassing
      the current understanding of this unique neoplasm is presented. Discussion
      focuses on clinical features, pathogenesis, disease outcome, and relation to the 
      duration of dialysis. The macroscopic and characteristic microscopic features are
      described with illustrations. Compared with previous opinion, compiled
      immunohistochemical data may now allow for recognition of a unique
      immunophenotypic pattern of ACD-RCC. Distinction of ACD-RCC from clear cell and
      papillary RCCs based on molecular genetic information is deliberated, including a
      summary of the most frequently detected cytogenetic abnormalities. The key
      morphologic and immunophenotypic patterns used to distinguish this entity from a 
      comprehensive differential diagnosis are provided.
FAU - Foshat, Michelle
AU  - Foshat M
FAU - Eyzaguirre, Eduardo
AU  - Eyzaguirre E
AD  - From the Department of Pathology, University of Texas Medical Branch, Galveston.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Arch Pathol Lab Med
JT  - Archives of pathology & laboratory medicine
JID - 7607091
RN  - 0 (Biomarkers, Tumor)
SB  - AIM
SB  - IM
MH  - Biomarkers, Tumor/metabolism
MH  - Carcinoma, Renal Cell/metabolism/*pathology/therapy
MH  - Chromosome Aberrations
MH  - Diagnosis, Differential
MH  - Humans
MH  - Kidney/metabolism/*pathology
MH  - Kidney Diseases, Cystic/metabolism/*pathology/therapy
MH  - Kidney Neoplasms/metabolism/*pathology/therapy
MH  - Prognosis
MH  - Treatment Outcome
EDAT- 2017/03/30 06:00
MHDA- 2017/04/19 06:00
CRDT- 2017/03/30 06:00
AID - 10.5858/arpa.2016-0123-RS [doi]
PST - ppublish
SO  - Arch Pathol Lab Med. 2017 Apr;141(4):600-606. doi: 10.5858/arpa.2016-0123-RS.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>